Ensuring quality of healthcare products is one of the key pillars in regulatory responsibilities, for industry, manufacturers and regulators. The contribution of Chemistry, Manufacturing and Controls (CMC) to a successful control of quality in pharmaceutical products spans from product development and manufacture, process validation to post-market variation changes, as well as an optimal quality management system. This module provides the foundation in understanding the regulatory science behind the development, manufacturing and control of pharmaceuticals, including the global guidance that shapes the regulatory processes. Besides promoting good submissions and evaluation practices, the module aims to enhance regulatory convergence and cooperation on CMC regulation.
Due to the limited availability of seats, early registration is strongly recommended.

Click
here for a step by step guide on how to register.
Click here to find out more about the Course Fees.
The Centre of Regulatory Excellence is an accredited provider for Continuing Professional Education (CPE) for Pharmacists and Continuing Medical Education (CME) for Doctors.
Continuing education credits are available for CoRE events through the Singapore Pharmacy Council and the Singapore Medical Council subject to their respective approvals.
Attendees who wish to avail of the credits are required to sign the relevant registration form along with their CPE/CME number on the day of the events.
Should the event be conducted online, please provide your CPE/CME number in the respective e-registration form.
The attendee’s registration details will be submitted after the event and credited upon receiving respective approvals.

Date and Time
18 Mar 2019 @ 09:00 - 22 Mar 2019 @ 18:00
Speaker

DR MOHEB NASR
Principal
Nasr Pharma Regulatory Consulting (NPRC)

DR SARAH POPE MIKSINSKI
Senior Director
Global Regulatory Affairs
AstraZeneca

DR ROGER NOSAL
Vice President
Global Head CMC
Pfizer

MR ARUN MISHRA
Executive Vice President
Regulatory Affairs (Indian Sub Continent)
GSK Consumer Healthcare Ltd

DR STEPHAN ROENNINGER
Director
External Affairs Europe
International Quality
Amgen

DR WASSIM NASHABEH
Vice President
Global Head
Policy and International Operations
Roche

Dr Rachel Specht
Scientist Genentech, a member of the Roche Group
Dr Bruno Rubrecht
Head
Product Quality Strategy & Lifecycle - Incoming Materials/Secondary
GSK Vaccines

Dr Tony Jarman
Principal Evaluator
Pharmaceutical Chemistry Section
Scientific Evaluation Branch
Therapeutic Goods Administration (TGA)
.tmb-thumbnail.jpg?Culture=en&sfvrsn=55476a6c_1)
Ms Lim Bee Yee
Senior Principal Assistant Director
New Drug Section
National Pharmaceutical Regulatory Agency (NPRA)

Dr Maria S. Bruno
Director Pharmaceutical Technology Operations
MSD International GmbH

Dr Sannie Chong
Head APAC Technical Regulatory Policy
Roche